References

Ali J, Ali M, Baboota S, Sahani JK Potential of nanoparticulate drug delivery systems by intranasal administration. Curr Pharm Des. 2010; 16:(14)1644-53

Permeability issues in nasal. 2002. http//www.answers.com/topics/injection (accessed 14 November 2012)

Boal WL, Leiss JK, Sousa S The national study to prevent blood exposure in paramedics: Exposure reporting. American Journal of Industrial Medicine. 2008; 51:(3)213-22

Barton ED, Ramos J, Cowell C Intranasal administration of naloxone by paramedics. Pre Hospital Emergency Care Journal. 2002; 6:(1)54-8

USA: Springer; 2007

Daniel B, Wassel J, Gilligan R Child development for childcare and protection workers, 2nd Edn. London: Jessica Kingsley; 2010

Dekker MNew York: Informa HealthCare; 2002

Ghali A, Mahfouz A, Al-Bahrani M Preanesthetic medication in children: A comparison of Intranasal dexmedocomidine versus oral Midazolam. Saudi J Anaesth. 2011; 5:(4)387-91

Gregory P, Mursell IChichester: Wiley-Blackwell; 2010

Holsti M, Sil BL, Firth SD Pre-hospital Intranasal Midazolam for the treatment of paediatric seizures. Peadiatr Emerg Care. 2007; 23:(3)148-53

Huizing EH, de Groot JAM, 5th Edn. New York: Thieme; 2003

Illum L Nasal Drug Delivery: Possibilities, Problems and Solutions J. Control Release. 2003; 87:187-98

Jain KK Drug Delivery System, 9th Edn. Totowa, New Jersey, USA: Human Press; 2008

Kao HD, Traboulsi A, Itoh S Enhancement of the Systemic and CNS Specific Delivery of L-dopa by the Nasal Administration of its Water Soluble Prodrugs. Pharm Res. 2000; 17:(8)978-84

2011. http//www.EMSWorld.com (accessed 15 November 2012)

Kerr D, Kelly AM, Dietze P Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose’. Addiction. 2009; 104:(12)2067-74

2001. http//www.intranasal/deliverytechniques/default.htm (accessed 12 November 2012)

McKibbon KA Evidence Based Practice. Bulletin of the Medical Library Association. 1998; 86:(3)396-401

Mittal P, Manohar R, Rawat AK Comparative study of intranasal midazolam and intravenous diazepam sedation for procedures and seizures. Indian Journal of Paediatrics. 2006; 73:(11)975-8

2011. http//www.biomedcentral.com/1471-2377/11/126 (accessed 15 November 2012)

Intranasal drug delivery: How, Why and What for?. 2009.

Price Lists various (2012). 2012. http//www.spservices.co.uk (accessed 28 November 2012)

Sackett DL Evidence based medicine:what it it and what it isn’t?’. BMJ. 1996; 312

Taddio A, llersich A, Ipp M Physical intervention and injection techniques for reducing injection pain during routine childhood immunisations systematic review of RCT and Quasi-RCT. Clinical Therapeutics. 2009; 3:(2)48-76

Thorne RG, Pronk GJ, Padmanabhan V Delivery of Insulin-like Growth Factor-I to the Rat Brain and Spinal cord Along Olfactory and Trigeminal Pathways Following Intranasal Administration. Neuroscience. 2005; 127:(2)481-96

Tortora G, Derrickson B, 13th Edn. Hooken, New Jersey, USA: Wiley and Sons; 2011

Turker S, Onur E, Ozer Y Nasal Route and Drug Delivery Systems. Pharmacy World and Science. 2004; 26:(3)137-42

Vyas TK, Shahiwala A, Marathe S Intranasal Drug Delivery for Brain Targeting. Curr Drug Deliv. 2005; 2:(2)165-75

Westin U, Piras E, Jansson B Transfer of Morphine Along the Olfactory Pathway to the Central Nervous System After Nasal Administration to Rodents. European Journal Pharmaceutical Science. 2005; 24:565-73

Use of intranasal drug administration in the pre-hospital setting

07 December 2012
Volume 4 · Issue 12

Abstract

This article explores the benefits of intranasal as a recommended route for drug delivery in the pre-hospital setting for healthcare professionals. It is currently used in Australia, USA and some UK Ambulance services and remains a preferred route in certain patient groups. Intranasal can lead to a reduction in needle stick injuries for the healthcare professional and allowing immediate drug therapy in a emergency setting for bystanders. Randomised control trial's and evidence-based practice to discuss the absorption rate and different drugs that could be used through this route. After reading this article paramedics should be more aware of this safe route and its benefits in the emergency setting.

Drug administration within the pre-hospital setting is currently seen via various routes. Oral, per rectal, intramuscular (IM) and intravenous (IV) are widely accepted for various drug delivery systems. Intranasal (IN) administration is something relatively new and currently relies on evidence–based practice to strengthen its use in the pre-hospital setting. The paramedic profession is progressing and using evidence–besed practice as a reliable and proven scientific route, studied by experts who evaluate evidence critically (College of Paramedics (CoP) 2008).

This article will explore the background of intranasal drug administration within the prehospital setting.There will be discussion around the pathophysiology of intranasal therapy, the different patient groups that would benefit and an awareness of the different types of drugs that could be used from intranasal drug delivery system. Strengths and limitations of intranasal will be reviewed through evaluating research and evidence based practice, while also incorporating arguments for comparison modes of administration, such as IM therapy. An insight regarding ethical issues and the paramedic's accountability will then be discussed before a formative conclusion is reached.

Subscribe to get full access to the Journal of Paramedic Practice

Thank you for visiting the Journal of Paramedic Practice and reading our archive of expert clinical content. If you would like to read more from the only journal dedicated to those working in emergency care, you can start your subscription today for just £48.

What's included

  • CPD Focus

  • Develop your career

  • Stay informed